Current Ratio in % of Aptevo Therapeutics Inc. from Q1 2017 to Q3 2025

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Aptevo Therapeutics Inc. quarterly Current Ratio history and change rate from Q1 2017 to Q3 2025.
Aptevo Therapeutics Inc. Current Ratio for the quarter ending 30 Sep 2025 was 217 %, a 6.24% increase year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Change (%)

Aptevo Therapeutics Inc. Quarterly Current Ratio (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	217	+12.8	+6.24%	30 Sep 2025
Q2 2025	158	-81.9	-34.1%	30 Jun 2025
Q1 2025	148	-127	-46.2%	31 Mar 2025
Q4 2024	178	-164	-47.9%	31 Dec 2024
Q3 2024	204	-149	-42.1%	30 Sep 2024
Q2 2024	240	-114	-32.1%	30 Jun 2024
Q1 2024	275	-107	-28.1%	31 Mar 2024
Q4 2023	341	+77	+29.1%	31 Dec 2023
Q3 2023	353	+148	+72.5%	30 Sep 2023
Q2 2023	354	+165	+87.8%	30 Jun 2023
Q1 2023	382	+203	+113%	31 Mar 2023
Q4 2022	264	+75.8	+40.2%	31 Dec 2022
Q3 2022	205	-14.4	-6.59%	30 Sep 2022
Q2 2022	188	-63.1	-25.1%	30 Jun 2022
Q1 2022	180	-79.8	-30.8%	31 Mar 2022
Q4 2021	189	-98.6	-34.3%	31 Dec 2021
Q3 2021	219	+75	+52.1%	30 Sep 2021
Q2 2021	251	+148	+144%	30 Jun 2021
Q1 2021	259	+133	+105%	31 Mar 2021
Q4 2020	287	+135	+88.5%	31 Dec 2020
Q3 2020	144	-64	-30.8%	30 Sep 2020
Q2 2020	103	-207	-66.8%	30 Jun 2020
Q1 2020	126	-209	-62.3%	31 Mar 2020
Q4 2019	152	-217	-58.7%	31 Dec 2019
Q3 2019	208	-223	-51.7%	30 Sep 2019
Q2 2019	310	-205	-39.8%	30 Jun 2019
Q1 2019	335	-232	-40.9%	31 Mar 2019
Q4 2018	369	-225	-37.9%	31 Dec 2018
Q3 2018	431	-114	-20.9%	30 Sep 2018
Q2 2018	515	+31.2	+6.46%	30 Jun 2018
Q1 2018	567	+163	+40.2%	31 Mar 2018
Q4 2017	594			31 Dec 2017
Q3 2017	545			30 Sep 2017
Q2 2017	483			30 Jun 2017
Q1 2017	405			31 Mar 2017

* An asterisk sign (*) next to the value indicates that the value is likely invalid.